Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PHILLIP MADONIA

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1871685917
CMS profile
387975
Location
MOBILE, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$92.02

4 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $92.02 4

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Organon LLC $44.23 2
MAYNE PHARMA COMMERCIAL LLC $26.90 1
Bayer Healthcare Pharmaceuticals Inc. $20.89 1

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PHILLIP MADONIA

NPI 1871685917 · CMS profile ID 387975

Allopathic & Osteopathic Physicians / Obstetrics & Gynecology

MOBILE, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1871685917?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PHILLIP MADONIA, NPI 1871685917, CMS profile ID 387975. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1871685917?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). PHILLIP MADONIA, NPI 1871685917, CMS profile ID 387975. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1871685917?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
PHILLIP MADONIA, NPI 1871685917, CMS profile ID 387975, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1871685917?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

4 matching records · $92.02 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 4 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–4 of 4.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Organon LLC $21.1208/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237789022 CMS
MAYNE PHARMA COMMERCIAL LLC $26.9006/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1254287522 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.8904/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225634592 CMS
Organon LLC $23.1103/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237789024 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $6,041.25 51
PY2020 $3,326.54 76
PY2021 $4,257.71 103
PY2022 $356.73 29
PY2023 $163.74 12
PY2024 $57.89 3
PY2025 $92.02 4

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $17,817.00 1
PY2023 Principal investigator $31,692.89 11
PY2022 Principal investigator $73,808.12 42
PY2021 Principal investigator $136,211.96 66
PY2020 Principal investigator $150,491.85 54
PY2019 Principal investigator $150,120.87 49

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

42 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $332.80 12/08/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890370121
Principal investigator 1 ABBVIE INC. $45.02 11/17/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain No dispute reported 06/30/2026 889821321
Principal investigator 1 ABBVIE INC. $490.00 11/17/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890368161
Principal investigator 1 ABBVIE INC. $21.49 11/17/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890368241
Principal investigator 1 ABBVIE INC. $800.00 11/15/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain No dispute reported 06/30/2026 889820833
Principal investigator 1 Evofem Biosciences, Inc. $1,000.00 11/15/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900660183
Principal investigator 1 Evofem Biosciences, Inc. $1,300.00 11/15/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900660581
Principal investigator 1 Evofem Biosciences, Inc. $200.00 11/15/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900660583
Principal investigator 1 ABBVIE INC. $3,717.94 10/13/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890368243
Principal investigator 1 Evofem Biosciences, Inc. $1,034.43 09/09/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900661891
Principal investigator 1 ABBVIE INC. $166.40 09/07/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890366381
Principal investigator 1 Mylan Technologies Inc. $61.00 08/26/2022 Non-covered Recipient Entity
MOBILE OBGYN, PC
PHASE 3, MULTICENTER, OPEN-LABEL, SINGLE ARM STUDY OF MR-100A-01 IN WOMEN OF CHILDBEARING POTENTIAL TO EVALUATE CONTRACEPTIVE EFFICACY AND SAFETY No dispute reported 06/30/2026 962739947
Principal investigator 1 Evofem Biosciences, Inc. $65.00 08/19/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900661665
Principal investigator 1 ABBVIE INC. $1,214.64 08/18/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain No dispute reported 06/30/2026 889806889
Principal investigator 1 ABBVIE INC. $970.50 08/11/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890366379
Principal investigator 1 Evofem Biosciences, Inc. $250.00 08/09/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900659949
Principal investigator 1 Evofem Biosciences, Inc. $1,549.72 07/27/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900661607
Principal investigator 1 Evofem Biosciences, Inc. $1,861.97 07/21/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900661605
Principal investigator 1 ABBVIE INC. $1,138.00 07/14/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain No dispute reported 06/30/2026 889800975
Principal investigator 1 Evofem Biosciences, Inc. $10,408.53 07/08/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900661603
Principal investigator 1 ABBVIE INC. $166.40 07/05/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890365375
Principal investigator 1 ABBVIE INC. $1,186.82 06/23/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890364409
Principal investigator 1 ABBVIE INC. $541.44 05/05/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain No dispute reported 06/30/2026 889790415
Principal investigator 1 ABBVIE INC. $1,147.12 04/07/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain No dispute reported 06/30/2026 889784601
Principal investigator 1 Evofem Biosciences, Inc. $2,694.65 03/31/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900661285
Principal investigator 1 ABBVIE INC. $535.04 03/17/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
Long-Term Safety Study of Elagolix in Combination With Estradiolx2FNorethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 890361059
Principal investigator 1 Evofem Biosciences, Inc. $2,353.49 03/17/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900661283
Principal investigator 1 ABBVIE INC. $2,231.06 03/10/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain No dispute reported 06/30/2026 889780541
Principal investigator 1 Evofem Biosciences, Inc. $9,674.15 03/10/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900661281
Principal investigator 1 Evofem Biosciences, Inc. $2,174.22 02/23/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900659817
Principal investigator 1 Evofem Biosciences, Inc. $5,637.95 02/17/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900659513
Principal investigator 1 Evofem Biosciences, Inc. $116.16 02/17/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900661989
Principal investigator 1 ABBVIE INC. $804.10 02/16/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 889777487
Principal investigator 1 ABBVIE INC. $1,510.14 02/10/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain No dispute reported 06/30/2026 889776649
Principal investigator 1 Evofem Biosciences, Inc. $2,353.49 02/10/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900660479
Principal investigator 1 Evofem Biosciences, Inc. $300.00 02/10/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900661955
Principal investigator 1 Evofem Biosciences, Inc. $1,578.63 02/03/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900660477
Principal investigator 1 ABBVIE INC. $5,381.88 02/01/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain No dispute reported 06/30/2026 889775167
Principal investigator 1 Evofem Biosciences, Inc. $4,585.53 01/20/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900661715
Principal investigator 1 ABBVIE INC. $332.80 01/13/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No dispute reported 06/30/2026 889773823
Principal investigator 1 Evofem Biosciences, Inc. $803.77 01/07/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNEOCOLOGY PC
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) No dispute reported 06/30/2026 900661713
Principal investigator 1 ABBVIE INC. $1,071.84 01/06/2022 Non-covered Recipient Entity
MOBILE OBSTETRICS & GYNECOLOGY PC
A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain No dispute reported 06/30/2026 889772107